PharmacoEconomics

The New Myth: The Social Value of the QALY
pp. 1-4(4)
Authors: Brouwer, Werner; Job van Exel,; Baker, Rachel; Donaldson, Cam

The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
pp. 5-15(11)
Authors: Fattore, Giovanni; Jommi, Claudio

Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies
pp. 17-32(16)
Authors: Anonychuk, Andrea M.; Tricco, Andrea C.; Bauch, Chris T.; Pham, Ba'; Gilca, Vladimir; Duval, Bernard; John-Baptiste, Ava; Woo, Gloria; Krahn, Murray

Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis
pp. 33-44(12)
Authors: Rogers, Gabriel; Garside, Ruth; Mealing, Stuart; Pitt, Martin; Anderson, Rob; Dyer, Matthew; Stein, Ken; Somerville, Margaret

Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination
pp. 45-56(12)
Authors: Pradas-Velasco, Roberto; Antoñanzas-Villar, Fernando; Martínez-Zárate, María Puy

Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study
pp. 57-73(17)
Authors: Cruess, Alan F.; Zlateva, Gergana; Xu, Xiao; Soubrane, Gisèle; Pauleikhoff, Daniel; Lotery, Andrew; Mones, Jordi; Buggage, Ronald; Schaefer, Caroline; Knight, Tyler; Goss, Thomas F.

Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections
pp. 75-90(16)
Authors: Robin de Vries,; Daenen, Simon; Tolley, Keith; Glasmacher, Axel; Prentice, Archie; Howells, Sarah; Christopherson, Hariette; Lolkje T.W. de Jong-van den Berg,; Postma, Maarten J.